New software to detect overdose risk among drug users

November 29, 2012

A new e-health tool that could help reduce the number of drug-related deaths in Europe will be launched in Brussels today.

The tool, developed by the Orion Project, financed by the European Commission and led by the University of St Andrews, is the first of its kind.  If rolled out successfully, researchers say the tool could help to significantly reduce cases of drug overdose.

Gerald Humphris, Professor of at St Andrews - one of the 4 European research groups involved in the research - said in advance of the launch, "Drug use is one of the major causes of health problems and mortality among young people in Europe and this is a concern for the and regulators alike; this is why we were keen to develop a new tool to detect and raise awareness of the risks of drug overdose.

"The findings from our tests have shown that 45% of patients would consider changing their drug taking behaviour as a result of using the software."

The software is designed to help both patients and medical professionals identify key factors that lead to fatal .

Ms Antigoni Papadopoulou, Member of the European Parliament for Cyprus and convenor of the launch said. "Over the last decade, Europe has experienced about one overdose death every hour.  Europe needs to support more tools and projects like this one that will help policy makers to understand how to prevent and reduce drug demand, particularly among the younger generations."

Representatives from EU Member States are meeting at the to discuss a draft of the EU's drug strategy for 2013-2020. The strategy aims to contribute to a reduction in drug demand use and drug supply within the EU, as well as the health and social risks and harms caused by . The framework of this strategy will serve as basis for two consecutive 4 year EU Drugs Action plans.

Explore further: Bristol-Pfizer anticlot drug gets key EU approval

More information: orion-euproject.com/

Related Stories

Bristol-Pfizer anticlot drug gets key EU approval

November 20, 2012
European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.

How men's lifestyles double their risk of an early death

June 17, 2011
A University of Sussex psychologist is one of the key authors of a major new report that reveals that death rates of men aged 16-64 is twice that of women in the same age range in the European Union.

Methadone linked to 30 percent of painkiller overdoses

July 4, 2012
The prescription drug methadone is linked to over 30 percent of painkiller overdose deaths, according to a report released by the Centers for Disease Control (CDC) and Prevention Tuesday.

Calls for policy changes as lives put at risk by bureaucracy

February 15, 2012
A European Parliament event to discuss how EU legislation has negatively affected the treatment received by children and adolescents has marked International Childhood Cancer Day - 15th February.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.